114 related articles for article (PubMed ID: 9720716)
1. Anticoagulant effects of synthetic retinoids.
Koyama T; Shibakura M
Leuk Lymphoma; 1998 Sep; 31(1-2):71-80. PubMed ID: 9720716
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant effects of synthetic retinoids and activated vitamin D3.
Koyama T; Hirosawa S
Semin Thromb Hemost; 1998; 24(3):217-26. PubMed ID: 9701451
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant effects of synthetic retinoids mediated via different receptors on human leukemia and umbilical vein endothelial cells.
Shibakura M; Koyama T; Saito T; Shudo K; Miyasaka N; Kamiyama R; Hirosawa S
Blood; 1997 Aug; 90(4):1545-51. PubMed ID: 9269772
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant effects of retinoic acids on leukemia cells.
Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
[TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
López-Pedrera C; Barbarroja N; Buendía P; Torres A; Dorado G; Velasco F
Haematologica; 2004 Mar; 89(3):286-95. PubMed ID: 15020266
[TBL] [Abstract][Full Text] [Related]
6. [Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells].
Zhang XH; Hu Y; Hong M; Xia LH; Guo T; Shen GX; Wei WN; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):391-5. PubMed ID: 17493354
[TBL] [Abstract][Full Text] [Related]
7. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
Falanga A; Consonni R; Marchetti M; Locatelli G; Garattini E; Passerini CG; Gordon SG; Barbui T
Blood; 1998 Jul; 92(1):143-51. PubMed ID: 9639510
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells.
Koyama T; Hirosawa S; Kawamata N; Tohda S; Aoki N
Blood; 1994 Nov; 84(9):3001-9. PubMed ID: 7949172
[TBL] [Abstract][Full Text] [Related]
9. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
Guo W; Wang H; Zhao W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
[TBL] [Abstract][Full Text] [Related]
10. [Retinoid therapy for autoimmune diseases].
Fukasawa H; Kagechika H; Shudo K
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):114-26. PubMed ID: 16819260
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes.
Koyama T; Shibakura M; Ohsawa M; Kamiyama R; Hirosawa S
Blood; 1998 Jul; 92(1):160-7. PubMed ID: 9639512
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of tissue factor expression on NB4 cells down-regulated by all-trans retinoic acid and arsenic trioxide].
Guo W; Wang H; Zhao W; Qu B; Pan L; Zhu J; Chu H; Wang X
Zhonghua Xue Ye Xue Za Zhi; 2000 May; 21(5):240-3. PubMed ID: 11876987
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway.
López-Boado YS; Klaus M; Dawson MI; López-Otín C
J Biol Chem; 1996 Dec; 271(50):32105-11. PubMed ID: 8943263
[TBL] [Abstract][Full Text] [Related]
15. The role of RAR and RXR activation in retinoid-induced tissue factor suppression.
Tenno T; Botling J; Oberg F; Jossan S; Nilsson K; Siegbahn A
Leukemia; 2000 Jun; 14(6):1105-11. PubMed ID: 10865976
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties.
Marchetti M; Vignoli A; Bani MR; Balducci D; Barbui T; Falanga A
Haematologica; 2003 Aug; 88(8):895-905. PubMed ID: 12935977
[TBL] [Abstract][Full Text] [Related]
17. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
[TBL] [Abstract][Full Text] [Related]
18. Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.
Hashimoto Y; Kagechika H; Kawachi E; Shudo K
Jpn J Cancer Res; 1988 Apr; 79(4):473-83. PubMed ID: 2838445
[TBL] [Abstract][Full Text] [Related]
19. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
